Literature DB >> 6219901

Biliary excretion of piperacillin.

E W Taylor, V Poxon, J Alexander-Williams, D Jackson.   

Abstract

1. The excretion of piperacillin sodium in bile was studied after intravenous injection of 2 g (n = 5) and 4 g (n = 7). All patients had undergone cholecystectomy and exploration of the common bile duct for cholelithiasis. Bile, serum and urine concentrations were measured by a microbiological technique. 2. Peak concentrations of piperacillin were found in bile at 150 minutes after 4 g and at 210 minutes after 2 g. 3. Both the concentration of piperacillin in bile at the end of a 6 1/2 hour study and the calculated mean bile concentration of piperacillin were above the minimum inhibitory concentration (MIC) of this drug for organisms commonly found in acute biliary tract infections. We believe piperacillin may be useful in the management of such conditions.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6219901     DOI: 10.1177/030006058301100106

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  7 in total

1.  The complex dynamics of antimicrobial activity in the human gastrointestinal tract.

Authors:  Louis B Rice
Journal:  Trans Am Clin Climatol Assoc       Date:  2013

Review 2.  Antibiotics and gastrointestinal colonization by vancomycin-resistant enterococci.

Authors:  L B Rice
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-12       Impact factor: 3.267

3.  Effects of probiotics on acquisition and spread of multiresistant enterococci.

Authors:  Marieke J A de Regt; Rob J L Willems; Ronald J Hené; Peter D Siersema; Harald J J Verhaar; Titia E M Hopmans; Marc J M Bonten
Journal:  Antimicrob Agents Chemother       Date:  2010-04-19       Impact factor: 5.191

4.  Biliary excretion of ciprofloxacin and piperacillin in the obstructed biliary tract.

Authors:  S J van den Hazel; X H de Vries; P Speelman; J Dankert; G N Tytgat; K Huibregtse; D J van Leeuwen
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

5.  Piperacillin in early neonatal infection.

Authors:  M Placzek; A Whitelaw; S Want; M Sahathevan; J Darrell
Journal:  Arch Dis Child       Date:  1983-12       Impact factor: 3.791

6.  Decreased biliary excretion of piperacillin after percutaneous relief of extrahepatic obstructive jaundice.

Authors:  J I Blenkharn; N Habib; D Mok; L John; G A McPherson; R N Gibson; L H Blumgart; I S Benjamin
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

Review 7.  Emergence of vancomycin-resistant enterococci.

Authors:  L B Rice
Journal:  Emerg Infect Dis       Date:  2001 Mar-Apr       Impact factor: 6.883

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.